Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

NCT07478848 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Large B Cell Lymphoma
Non Hodgkin Lymphoma (NHL)
Diffuse Large B Cell Lymphoma (DLBCL)
Diffuse Large B Cell Lymphoma Refractory
Diffuse Large B Cell Lymphoma Relapsed

Interventions

DRUG: Vancomycin 125mg

Sponsor

Abramson Cancer Center at Penn Medicine

Collaborators

[object Object]